Skip to content
GLP-1 Decoder

Saxenda for Prediabetes: Evidence, Eligibility, Coverage

Saxenda is not FDA approved for prediabetes. It is approved for weight loss. Some doctors prescribe it when one of those uses also applies. In SCALE Obesity and Prediabetes, people on Saxenda lost 7.4% of body weight on average, vs 3% on placebo.

Active ingredient
liraglutide
How it is taken
daily injection
Approved for
Weight loss
Best result (SCALE Obesity and Prediabetes)
7.4% weight loss

Saxenda overview

How long it remains in your body
100%50%25%0%013 h26 h39 h2.2 d2.7 d50%25%12.5%time after the dose

About 13 hours is its half-life: once 13 h passes, half is gone, while five half-lives leave about 3% behind (2.7 d).

Main study weight loss result
Saxenda (SCALE Obesity and Prediabetes)7.4%Placebo3%

SCALE Obesity and Prediabetes, 56 weeks: body weight fell 7.4% versus 3% on placebo.

Sources: FDA label (DailyMed).

Who qualifies?

Who qualifies for Saxenda
Who sets the ruleWho qualifies
FDA labelThis covers long-term weight loss and keeping it off, with diet and activity. It applies to adults and children with obesity who are 12 and older (over 60 kg), or to adults who have overweight together with a weight-related condition.
Typical commercial plan (Aetna policy)BMI 30 or higher
Typical commercial plan (Aetna policy)BMI 27 or higher with a weight-related condition
Typical commercial plan (Aetna policy)first, 6 months of a diet and activity program

Sources: FDA DailyMed label, aetna.com.

Trial results for prediabetes

None of these trials enrolled only prediabetes; the people studied were adults with obesity or overweight, and no type 2 diabetes.

Saxenda trials in prediabetes
TrialMedicineWho took partLengthPeopleMain resultComparison
SCALE Obesity and Prediabetes SaxendaAdults with obesity or overweight, and no type 2 diabetes56 weeks3,7317.4% weight loss3% on placebo

Sources for the study: SCALE Obesity and Prediabetes (FDA label (DailyMed)).

What is different for prediabetes?

Prediabetes information from the Saxenda label
What changesWhat the label says
HypoglycemiaLow blood sugar is more likely when you take it with insulin or a sulfonylurea, and those doses may need lowering.
Taken with insulin or sulfonylureasWith type 2 diabetes, taking it with insulin or a sulfonylurea raises the chance of low blood sugar.

According to the FDA labels: FDA label (DailyMed).

Label warnings: FDA label on DailyMed.

Coverage for prediabetes

When a GLP-1 is used for weight loss alone, Medicare Part D does not cover it.

In places where Medicaid covers weight-loss GLP-1s, you normally need prior authorization.

Sources: humana.com, KFF.

Alternatives for prediabetes

GLP-1 medicines and prediabetes
MedicineFor prediabetesHow it is takenTrial result
SaxendaNot a listed usedaily injection7.4% weight loss
OzempicNot a listed useweekly injectionNot listed
WegovyNot a listed useweekly injection or daily tablet14.9% weight loss
RybelsusNot a listed usedaily tabletNot listed
MounjaroNot a listed useweekly injectionNot listed
ZepboundNot a listed useweekly injection20.9% weight loss
FoundayoNot a listed usedaily tablet11.1% weight loss
TrulicityNot a listed useweekly injectionNot listed
VictozaNot a listed usedaily injectionNot listed
ByettaNot a listed usetwice-daily injectionNot listed

Sources: FDA label (DailyMed).

What to ask your prescriber

Read the complete Saxenda prescribing details on DailyMed.